Variant report

Variant	nsv464607
Chromosome Location	chr7:80262830-80288854
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:80263770-80264169	HepG2	liver:	n/a	n/a
2	ARID3A	chr7:80284287-80284555	HepG2	liver:	n/a	n/a
3	ARID3A	chr7:80272116-80272564	HepG2	liver:	n/a	n/a
4	ATF2	chr7:80267578-80268064	GM12878	blood:	n/a	n/a
5	ATF2	chr7:80267373-80268134	GM12878	blood:	n/a	n/a
6	BATF	chr7:80267605-80267988	GM12878	blood:	n/a	n/a
7	BATF	chr7:80267647-80267923	GM12878	blood:	n/a	n/a
8	BCL11A	chr7:80267684-80267984	GM12878	blood:	n/a	n/a
9	BCL11A	chr7:80267588-80268026	GM12878	blood:	n/a	n/a
10	BCL3	chr7:80267478-80268093	GM12878	blood:	n/a	chr7:80267573-80267582
11	BCLAF1	chr7:80267523-80268057	GM12878	blood:	n/a	chr7:80267573-80267582
12	BHLHE40	chr7:80267457-80267965	GM12878	blood:	n/a	n/a
13	BRCA1	chr7:80288768-80289107	Hela-S3	cervix:	n/a	n/a
14	BRCA1	chr7:80263685-80264171	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr7:80268417-80268679	IMR90	lung:	n/a	chr7:80268544-80268555 chr7:80268542-80268553 chr7:80268544-80268553
16	CEBPB	chr7:80263790-80264179	A549	lung:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
17	CEBPB	chr7:80263820-80264077	HepG2	liver:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
18	CEBPB	chr7:80263870-80264032	K562	blood:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
19	CEBPB	chr7:80272188-80272426	HepG2	liver:	n/a	chr7:80272335-80272348 chr7:80272335-80272346
20	CEBPB	chr7:80263803-80264151	MCF-7	breast:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
21	CEBPB	chr7:80263773-80264293	IMR90	lung:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
22	CEBPB	chr7:80272830-80273384	MCF-7	breast:	n/a	n/a
23	CEBPB	chr7:80263864-80264074	HepG2	liver:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
24	CEBPB	chr7:80267337-80268157	GM12878	blood:	n/a	chr7:80267547-80267560 chr7:80267352-80267363 chr7:80267356-80267367
25	CEBPB	chr7:80263777-80264203	HepG2	liver:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
26	CEBPB	chr7:80272144-80272538	HepG2	liver:	n/a	chr7:80272335-80272348 chr7:80272335-80272346
27	CEBPB	chr7:80263632-80264325	A549	lung:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
28	CEBPB	chr7:80263755-80264281	Hela-S3	cervix:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
29	CEBPB	chr7:80272790-80273832	ECC-1	luminal epithelium:	n/a	n/a
30	CEBPB	chr7:80272158-80272462	HepG2	liver:	n/a	chr7:80272335-80272348 chr7:80272335-80272346
31	CEBPB	chr7:80263757-80264252	A549	lung:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
32	CEBPB	chr7:80268410-80268678	K562	blood:	n/a	chr7:80268544-80268555 chr7:80268542-80268553 chr7:80268544-80268553
33	CEBPB	chr7:80263785-80264123	ECC-1	luminal epithelium:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
34	CEBPB	chr7:80268377-80268683	HepG2	liver:	n/a	chr7:80268544-80268555 chr7:80268542-80268553 chr7:80268544-80268553
35	CEBPB	chr7:80272148-80272537	HepG2	liver:	n/a	chr7:80272335-80272348 chr7:80272335-80272346
36	CEBPB	chr7:80263869-80264105	ECC-1	luminal epithelium:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
37	CEBPB	chr7:80272854-80273198	ECC-1	luminal epithelium:	n/a	n/a
38	CEBPB	chr7:80268439-80268641	A549	lung:	n/a	chr7:80268544-80268555 chr7:80268542-80268553 chr7:80268544-80268553
39	CEBPB	chr7:80272811-80273219	MCF-7	breast:	n/a	n/a
40	CEBPB	chr7:80263826-80264127	HepG2	liver:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
41	CEBPB	chr7:80263676-80264299	MCF-7	breast:	n/a	chr7:80263980-80263991 chr7:80263979-80263992
42	CEBPD	chr7:80272223-80272481	HepG2	liver:	n/a	chr7:80272336-80272347
43	CHD1	chr7:80287800-80289162	IMR90	lung:	n/a	n/a
44	CHD2	chr7:80267673-80268042	GM12878	blood:	n/a	chr7:80267904-80267914 chr7:80267907-80267917
45	CHD2	chr7:80263854-80264150	Hela-S3	cervix:	n/a	n/a
46	CREB1	chr7:80267543-80268149	GM12878	blood:	n/a	n/a
47	CTCF	chr7:80288847-80289122	Spleen_OC	spleen:	n/a	chr7:80288970-80288988 chr7:80288971-80288987 chr7:80288965-80288986
48	CTCF	chr7:80288837-80289129	Medullo	brain:	n/a	chr7:80288970-80288988 chr7:80288971-80288987 chr7:80288965-80288986
49	CTCF	chr7:80288832-80289063	HepG2	liver:	n/a	chr7:80288970-80288988 chr7:80288971-80288987 chr7:80288965-80288986
50	CTCF	chr7:80288165-80289708	A549	lung:	n/a	chr7:80288970-80288988 chr7:80288971-80288987 chr7:80288965-80288986

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:80274460-80274510	AoSMC	blood vessel:	n/a
2	chr7:80274460-80274510	HL-60	blood:	n/a
3	chr7:80267619-80267669	HRPEpiC	eye:	n/a
4	chr7:80267619-80267669	K562	blood:	n/a
5	chr7:80275870-80275920	Hepatocyte	liver:	n/a
6	chr7:80275870-80275920	LNCaP	prostate:	n/a
7	chr7:80266930-80266980	HL-60	blood:	n/a
8	chr7:80274687-80274737	GM12891	blood:	n/a
9	chr7:80267619-80267669	HCPEpiC	choroid plexus:	n/a
10	chr7:80275870-80275920	HEK293	kidney:	embryo
11	chr7:80274460-80274510	BJ	skin:	n/a
12	chr7:80274460-80274510	AG09319	gingival:	n/a
13	chr7:80266930-80266980	GM06990	blood:	n/a
14	chr7:80267943-80267993	GM12878	blood:	n/a
15	chr7:80267619-80267669	T-47D	breast:	n/a
16	chr7:80267619-80267669	SK-N-SH	brain:	n/a
17	chr7:80274687-80274737	HCPEpiC	choroid plexus:	n/a
18	chr7:80274460-80274510	PFSK-1	brain:	n/a
19	chr7:80274687-80274737	H1-hESC	embryonic stem cell:	embryo
20	chr7:80267619-80267669	AoSMC	blood vessel:	n/a
21	chr7:80266930-80266980	AG04449	skin:	fetal
22	chr7:80274460-80274510	HRPEpiC	eye:	n/a
23	chr7:80274687-80274737	GM12878	blood:	n/a
24	chr7:80266930-80266980	PANC-1	pancreas:	n/a
25	chr7:80275870-80275920	CMK	blood:	n/a
26	chr7:80267619-80267669	NHBE	bronchial:	n/a
27	chr7:80267619-80267669	HEK293	kidney:	embryo
28	chr7:80274460-80274510	GM06990	blood:	n/a
29	chr7:80267619-80267669	AG04450	lung:	fetal
30	chr7:80267943-80267993	A549	lung:	n/a
31	chr7:80267619-80267669	BJ	skin:	n/a
32	chr7:80275870-80275920	HL-60	blood:	n/a
33	chr7:80275870-80275920	AG09309	skin:	n/a
34	chr7:80274460-80274510	AG09309	skin:	n/a
35	chr7:80266930-80266980	HRPEpiC	eye:	n/a
36	chr7:80267619-80267669	HUVEC	blood vessel:	n/a
37	chr7:80266930-80266980	Hepatocyte	liver:	n/a
38	chr7:80267943-80267993	AG10803	skin:	n/a
39	chr7:80274687-80274737	GM06990	blood:	n/a
40	chr7:80274687-80274737	A549	lung:	n/a
41	chr7:80274460-80274510	Caco-2	colon:	n/a
42	chr7:80267943-80267993	IMR90	lung:	fetal
43	chr7:80275870-80275920	GM12892	blood:	n/a
44	chr7:80275870-80275920	MCF10A-Er-Src	breast:	n/a
45	chr7:80274687-80274737	SK-N-MC	brain:	n/a
46	chr7:80274460-80274510	RPTEC	kidney:	n/a
47	chr7:80267943-80267993	U87	brain:	n/a
48	chr7:80267619-80267669	PANC-1	pancreas:	n/a
49	chr7:80266930-80266980	HEEpiC	esophagus:	n/a
50	chr7:80266930-80266980	K562	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:80057613..80058392-chr7:80288390..80289288,3	MCF-7	breast:
2	chr7:80263049..80265695-chr7:80267263..80270319,3	K562	blood:
3	chr7:80057471..80058066-chr7:80288234..80289022,3	MCF-7	breast:
4	chr7:80288156..80289657-chr7:80291382..80293831,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GNAI1-5	chr7:80266148-80266319	NONHSAT121746
2	lnc-GNAI1-5	chr7:80275968-80276531	NONHSAT121745
3	lnc-GNAI1-5	chr7:80275968-80276042	NONHSAT121746
4	lnc-GNAI1-5	chr7:80275404-80275497	NONHSAT121746
5	lnc-GNAI1-5	chr7:80275404-80275497	NONHSAT121745

Variant related genes	Relation type
CD36	TF binding region
CD36	CpG island
ENSG00000229436	chromatin interactions
ENSG00000135218	chromatin interactions

Extended variants
information (count: 1047 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:1047 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10216184	chr7:80262830-80262831	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs553074460	chr7:80262849-80262850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs117411981	chr7:80262872-80262873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs184217096	chr7:80262911-80262912	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs142394293	chr7:80262918-80262919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs555910084	chr7:80262933-80262934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs537430095	chr7:80262956-80262957	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs574917792	chr7:80262993-80262994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs9784998	chr7:80263001-80263002	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs150426525	chr7:80263065-80263066	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs561561087	chr7:80263109-80263110	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs578177168	chr7:80263146-80263147	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs58408258	chr7:80263156-80263157	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs576975821	chr7:80263182-80263183	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs548291988	chr7:80263236-80263237	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs377689742	chr7:80263269-80263270	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs145450412	chr7:80263285-80263286	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs559715898	chr7:80263291-80263292	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs528860489	chr7:80263294-80263295	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs548626634	chr7:80263298-80263299	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs562257528	chr7:80263320-80263321	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs78207948	chr7:80263324-80263325	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs113047399	chr7:80263355-80263356	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs528074701	chr7:80263362-80263363	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs117512455	chr7:80263397-80263398	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs138168408	chr7:80263408-80263409	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs528109320	chr7:80263420-80263421	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs75283129	chr7:80263442-80263443	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs377394586	chr7:80263478-80263479	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs370445392	chr7:80263544-80263545	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs566834546	chr7:80263643-80263644	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs188681526	chr7:80263664-80263665	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs555871598	chr7:80263670-80263671	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs541884927	chr7:80263696-80263697	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs556384551	chr7:80263704-80263705	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs192781629	chr7:80263705-80263706	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs142740738	chr7:80263726-80263727	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs182091236	chr7:80263743-80263744	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs578157513	chr7:80263760-80263761	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs75424541	chr7:80263877-80263878	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs187090184	chr7:80263921-80263922	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs573265817	chr7:80263924-80263925	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs542236329	chr7:80263928-80263929	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs571361750	chr7:80263947-80263948	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs562170479	chr7:80263976-80263977	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs531289166	chr7:80264049-80264050	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs191478715	chr7:80264053-80264054	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs79842334	chr7:80264117-80264118	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs561760290	chr7:80264118-80264119	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs184359443	chr7:80264123-80264124	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Biliary cancer	19435499	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21750150	CNVD
Cancer	21183584	CNVD
Hepatocellular carcinoma	16750200	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Neurodevelopmental disorder	22521361	CNVD
Williams Syndrome	20824207	CNVD
Metanephric adenoma	20802469	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Williams-beuren syndrome	16826523	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	19318497	CNVD
Multiple myeloma	16616336	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Schizophrenia	17879154	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Autism	20858243	CNVD
Breast cancer	21611746	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:437 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:80258600-80264800	Weak transcription	Left Ventricle	heart
2	chr7:80259600-80263400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr7:80260000-80265600	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr7:80260200-80263400	Weak transcription	Muscle Satellite Cultured Cells	--
5	chr7:80260200-80263400	Weak transcription	HMEC	breast
6	chr7:80260200-80263400	Weak transcription	NHEK	skin
7	chr7:80260200-80264400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr7:80260400-80263200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr7:80260400-80263400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr7:80260400-80263400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr7:80260400-80265200	Weak transcription	Fetal Muscle Leg	muscle
12	chr7:80260400-80267200	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr7:80260400-80273400	Weak transcription	Small Intestine	intestine
14	chr7:80260600-80263400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr7:80260600-80263400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr7:80260600-80263400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr7:80260600-80263400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr7:80260600-80263400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr7:80260600-80263400	Weak transcription	Right Ventricle	heart
20	chr7:80260600-80263400	Weak transcription	NHDF-Ad	bronchial
21	chr7:80260600-80263400	Weak transcription	Osteobl	bone
22	chr7:80260600-80264000	Enhancers	Adipose Nuclei	Adipose
23	chr7:80260600-80267000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr7:80261200-80264600	Enhancers	Liver	Liver
25	chr7:80261200-80266200	Enhancers	Primary neutrophils fromperipheralblood	blood
26	chr7:80261400-80263400	Weak transcription	Skeletal Muscle Female	skeletal muscle
27	chr7:80261400-80263400	Weak transcription	NHLF	lung
28	chr7:80261600-80263400	Weak transcription	Fetal Lung	lung
29	chr7:80261600-80265200	Weak transcription	Psoas Muscle	Psoas
30	chr7:80261600-80266400	Enhancers	HepG2	liver
31	chr7:80261800-80265000	Weak transcription	Duodenum Smooth Muscle	Duodenum
32	chr7:80261800-80266800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
33	chr7:80262200-80264800	Enhancers	Hela-S3	cervix
34	chr7:80262400-80272600	Weak transcription	Pancreatic Islets	Pancreatic Islet
35	chr7:80262600-80263000	Weak transcription	Primary hematopoietic stem cells	blood
36	chr7:80262600-80263600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr7:80262600-80263800	Weak transcription	A549	lung
38	chr7:80262800-80263000	Enhancers	Primary B cells from cord blood	blood
39	chr7:80262800-80263200	Weak transcription	Fetal Heart	heart
40	chr7:80262800-80263200	Weak transcription	Skeletal Muscle Male	skeletal muscle
41	chr7:80262800-80263200	Enhancers	Monocytes-CD14+_RO01746	blood
42	chr7:80263000-80263600	Weak transcription	Primary B cells from cord blood	blood
43	chr7:80263000-80263800	Enhancers	Primary hematopoietic stem cells	blood
44	chr7:80263200-80264000	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr7:80263200-80264400	Enhancers	Fetal Heart	heart
46	chr7:80263200-80264600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr7:80263200-80266200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
48	chr7:80263400-80263600	Enhancers	Placenta	Placenta
49	chr7:80263400-80263600	Enhancers	Right Ventricle	heart
50	chr7:80263400-80263600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links